Skip to main content
. 2018 May 4;9(34):23608–23619. doi: 10.18632/oncotarget.25286

Figure 1.

Figure 1

Progression-free survival (PFS) in (A) all the patients and (B) according to molecular profile. Abbreviations: PFS: Progression free survival; TN = triple negative; HER 2+ = human epidermal growth factor receptor 2 overexpressed; HR+ = Hormone receptor positive.